XTL Biopharmaceuticals Lt... (XTLB)
NASDAQ: XTLB
· Real-Time Price · USD
1.33
-0.09 (-6.34%)
At close: Aug 15, 2025, 1:40 PM
1.41
6.02%
After-hours: Aug 15, 2025, 04:00 PM EDT
XTL Biopharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -10.85 | -5.91 | -4.18 | 8.46 | -4.84 | -5.69 | -3.74 | -1.94 | -2.2 | -1.84 | -7.27 | 6.38 | 1.80 | -11.34 | -6.09 | 15.35 |
PEG Ratio | 0.20 | 0.26 | 0.02 | -0.03 | -0.19 | 0.13 | 0.06 | -0.09 | 0.33 | -0.01 | 0.05 | -0.08 | -0.00 | 0.30 | 0.01 | 0.61 |
PS Ratio | 38.28 | 80.73 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.04 | 2.29 | 5.27 | 6.06 | 2.48 | 1.96 | 2.00 | 2.32 | 1.65 | 1.27 | 1.49 | 2.21 | 2.83 | 7.51 | 6.42 | 4.02 |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 0.61 | 0.81 | 12.23 | 11.43 | 9.93 | 14.09 | 15.34 | 12.21 | 20.35 | 29.52 | 31.26 | 24.00 | 27.00 | 34.99 | 25.47 | 27.61 |
Current Ratio | 0.61 | 0.81 | 12.23 | 11.43 | 9.93 | 14.09 | 15.34 | 12.21 | 20.35 | 29.52 | 31.26 | 24.00 | 27.00 | 34.99 | 25.47 | 27.61 |
Asset Turnover | 0.03 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -8.22 | -32.38 | -10.94 | n/a | -5.39 | -5.09 | -10.04 | n/a | n/a | -18.36 | -27.67 | n/a | n/a | -38.21 | n/a |
Return on Equity | -0.05 | -0.1 | -0.32 | 0.18 | -0.13 | -0.09 | -0.13 | -0.3 | -0.19 | -0.17 | -0.05 | 0.09 | 0.39 | -0.17 | -0.26 | 0.07 |
Return on Assets | -0.03 | -0.06 | -0.29 | 0.17 | -0.12 | -0.08 | -0.13 | -0.28 | -0.18 | -0.17 | -0.05 | 0.08 | 0.32 | -0.07 | -0.12 | 0.04 |
Return on Invested Capital | -0.13 | -0.11 | -0.19 | -0.06 | -0.09 | -0.06 | -0.06 | -0.08 | -0.06 | -0.04 | -0.04 | -0.04 | -0.04 | -0.07 | -0.08 | -0.03 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -0.15 | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -0.88 | -3.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -1.33 | -3.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -2.81 | -4.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.66 | -2.84 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |